Skip to main content
. Author manuscript; available in PMC: 2016 Dec 14.
Published in final edited form as: Cancer Cell. 2015 Dec 14;28(6):773–784. doi: 10.1016/j.ccell.2015.11.006

Figure 5. NAMPT inhibitor effect on NAD+-utilizing pathways in IDH mutant cancers.

Figure 5

Metabolites of the tricarboxylic acid (TCA) cycle in MGG152 cells were quantified by LC-MS after treatment with DMSO (36 hr, white bars) or FK866 (12.5 nM, 36 hr, black bars). Bar graphs represent the changes in FK866-treated cells relative to DMSO control.